Repeat Dose Toxicity News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Repeat Dose Toxicity. Real-time updates on events, politics, business and more.

Enzolytics, Inc. Announces U.S. Distribution of IPF Immune and Progress in each of its Therapeutic Platforms

December 13, 2022

COLLEGE STATION, TX / ACCESSWIRE / December 13, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).Enzolytics' focus is on the production and distribution of the Company's therapeutics and

United States South Africa Gaurav Chandra Joseph Cotropia Samsung Biologics Harry Zhabilov

Source: finanznachrichten.de

Enzolytics, Inc.: Enzolytics Reports Successful Completion of an MTD Tolerability Study of Its ITV-1 anti-HIV Therapeutic Leading to the Start of a 28-day GLP Toxicology Study

October 5, 2022

COLLEGE STATION, TX / ACCESSWIRE / October 5, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) ("ENZC" or the "Company"). The Company announces the completion of the first phase of the animal toxicology studies

United States Charles Cotropia While Enzolytics Inc Enzolytics Inc Company Contact Repeat Dose Toxicity

Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Repeat Dose Toxicity News Today

Enzolytics, Inc. Announces U.S. Distribution of IPF Immune and Progress in each of its Therapeutic Platforms

Enzolytics, Inc.: Enzolytics Reports Successful Completion of an MTD Tolerability Study of Its ITV-1 anti-HIV Therapeutic Leading to the Start of a 28-day GLP Toxicology Study

Explore More Categories